氘可来昔替尼(Deucravacitinib)的正确购买途径

Introduction: Deucravacitinib is commonly used to treat moderate to severe plaque psoriasis. The drug blocks a protein called tyrosine in the body. Substances called TYK2 play an important role in the process that causes swelling. By blocking TYK2, deuterated colexitinib can reduce the swelling (inflammation) seen in certain conditions, such as plaque psoriasis.

The correct way to purchase generic drugs of Deucravacitinib

The correct ways to purchase generic drugs include the following.

1. Regular pharmacies: Generic drugs of colexitinib are not currently available in China. Patients may need to go to regular pharmacies in listed countries to purchase them. For example, Bangladesh, especially large pharmacies, usually sell generic drugs of colexitinib.

2. Hospital pharmacy: After visiting a hospital in a country such as Bangladesh where generic drugs are on the market, if the hospital doctor issues a prescription for deuterated colexitinib, the patient can directly purchase the generic version of deuterated colexitinib at the hospital pharmacy.

3. Online pharmacies: Some online pharmacies approved by the state can also sell generic deuterated colexitinib. Patients can purchase it online, but they need to pay attention to the qualifications of the merchants to ensure the authenticity and safety of the drugs.

4. Medical service institutions: Patients can also purchase generic versions of drugs through domestic medical service institutions. After purchasing the drugs, they can obtain the drugs through direct mail, which is more convenient and fast.

When purchasing deuterated colexitinib, you should choose formal and legal channels to ensure the authenticity and safety of the drug. Understand the side effects, etc. before taking the medicine.

Precautions for Deucravacitinib

1. Hypersensitivity reactions: Hypersensitivity reactions, such as angioedema, have been reported in patients receiving Deucravacitinib. If a clinically significant hypersensitivity reaction occurs, appropriate treatment should be instituted and this product should be discontinued.

2. Risk of infection: Deuterated coxitinib may increase the risk of infection. Cases of serious infection have been reported in patients with psoriasis treated with deuterated colexitinib, and deuterated colexitinib should be avoided in patients with active or severe infections.

3. Tuberculosis assessment: Before starting treatment with deuterated colexitinib, the patient should be assessed for risk of tuberculosis (TB).

4. Risk of malignant tumors: In clinical trials, cases of malignant tumors, including lymphoma, have been reported in patients using deuterated colexitinib.

Deuterated colexitinib is not recommended for patients with severe hepatic impairment (Child-Pugh class C). There is currently a lack of sufficient research data on the safety of deuterated colexitinib in pregnant and lactating women. The use of this drug needs to be carefully considered and conducted under the guidance of a doctor.

Side effects of Deucravacitinib

Common side effects* of Deucravacitinib include upper respiratory tract infection, increased blood creatine phosphokinase, herpes simplex, oral ulcers, folliculitis, acne, hypertriglyceridemia and increased liver function. Serious side effects include allergic reactions, increased risk of infection, etc. Strictly follow your doctor's instructions when using deuterated colexitinib, and contact your doctor promptly if any questions or adverse reactions occur.